Загрузка...
Fremanezumab: First Global Approval
Fremanezumab-vfrm (hereafter referred to as fremanezumab) [AJOVY™] is a fully humanized monoclonal antibody (IgG2Δa) developed by Teva Pharmaceuticals to selectively target calcitonin gene-related peptide (a vasodilatory neuropeptide involved in the pathophysiology of migraine). Its use has been ass...
Сохранить в:
| Опубликовано в: : | Drugs |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422958/ https://ncbi.nlm.nih.gov/pubmed/30406901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-1004-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|